Loading company…
Newark, US-based biotechnology company developing oncology therapies intended to address unmet needs in cancer treatment.
Rain Therapeutics Inc. develops targeted cancer therapies that inhibit cancer cell growth through unique mechanisms, aimed at solid tumors and other cancers. It supplies hospitals, oncology clinics and research institutions, mainly in North America. Founded in 2017 in Newark, US, the company completed five deals, including a PIPE round on April 22, 2021, that raised USD 50.00 mn from investors including Adage Capital Management and BVF Partners. CEO Avanish Vellanki is a co-founder.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in